Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 6, 2011, Pages 963-967

  Igai, Hitoshi ^a   Matsuura, Natsumi ^a   Tarumi, Shintaro ^a   Chang, Sung Soo ^a   Misaki, Noriyuki ^a   Go, Tetsuhiko ^a   Ishikawa, Shinya ^a   Yokomise, Hiroyasu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Lung cancer; P T1aN0M0

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER PATIENT; CANCER STAGING; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS;

EID: 79955635243     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.09.008     Document Type: Article

References (22)

1. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., Tsuboi M., Vallieres E., Goldstraw P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
2. Kameyama K., Takahashi M., Ohata M., Igai H., Yamashina A., Matsuoka T., Nakagawa T., Okumura N. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. J Thorac Cardiovasc Surg 2009, 137:1180-1184.
3. Lyons G., Quadrelli S., Silva C., Vera K., Iotti A., Venditti J., Chertcoff J., Chimondeguy D. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T-factor. J Thorac Oncol 2008, 3:989-993.
4. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., Graziano S.L. Impact of tumor size on survival in stage I A non-small cell lung cancer: a case for subdividing stage I A disease. Lung Cancer 2003, 42:51-57.
5. Birim O., Kappetein A.P., Takkenberg J.J., van Klaveren R.J., Bogers A.J. Survival after pathological stage I A non-small cell lung cancer: tumor size matters. Ann Thorac Surg 2005, 79:1137-1141.
6. Christian C., Erica S., Uliano M. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer 2006, 54:185-191.
7. Hsu W.H., Huang C.S., Hsu H.S., Huang W.J., Lee H.C., Huang B.S., Huang M.H. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg 2007, 83:419-424.
8. Okada M., Nishio W., Sakamoto T., Uchino K., Yuki T., Nakagawa A., Tsubota N. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004, 78:216-221.
9. Matsuguma H., Nakahara R., Igarashi S., Ishikawa Y., Suzuki H., Miyazawa N., Honjo S., Yokoi K. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg 2008, 135:44-49.
10. Tsuchiya T., Akamine S., Muraoka M., Kamohara R., Tsuji K., Urabe S., Honda S., Yamasaki N. Stage I A non-small cell lung cancer: vessel invasion is poor prognostic factor and a new adjuvant chemotherapy. Lung Cancer 2007, 56:341-348.
11. Miyoshi K., Moriyama S., Kunimoto T., Nawa S. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137:429-434.
12. Tsuchiya T., Hashizume S., Akamine S., Muraoka M., Honda S., Tsuji K., Urabe S., Hayashi T., Yamasaki N., Nagayasu T. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest 2007, 132:170-177.
13. Nakagawa T., Okumura N., Kokado Y., Miyoshi K., Matsuoka T., Kameyama K. Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer. Ann Thorac Surg 2007, 83:204-208.
14. Lim E., Ali A., Theodorou P., Nicholson A.G., Ladas G., Golodstraw P. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg 2004, 127:1113-1118.
15. Li Y.N., Shi H.Z., Liang Q.L., Yang H.B., Huang G.M. Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis. Lung Cancer 2008, 60:183-192.
16. Fukui T., Katayama T., Ito S., Abe T., Hatooka S., Mitsudomi T. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer 2009, 66:309-313.
17. Inoue M., Minami M., Shiono H., Sawabata N., Ideguchi K., Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 2006, 131:988-993.
18. Nakamura K., Saji H., Nakajima R., Okada M., Asamura H., Shibata T., Nakamura S., Tada H., Tsuboi M. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010, 40:271-274.
19. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzales-Larriba J.L., Grodzki T., Pereira J.R., Le Groumellec A., Lorusso V., Clary C., Torres A.J., Dahabreh J., Souquet P.J., Astudillo J., Fournel P., Artal-Cortes A., Jassem J., Koubkova L., His P., Riggi M., Hurteloup P. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Naverbine International Trialist Association [ANITA]): a randomized controlled trial. Lancet Oncol 2006, 7:719-727.
20. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Eng J Med 2004, 350:351-360. International Adjuvant Lung Cancer Trial Collaborative Group.
21. Kato H., Ichinose Y., Ohta M., Hata E., Tsubota N., Tada H., Watanabe Y., Wada H., Tsuboi M., Hamajima N., Ohta M. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Eng J Med 2004, 350:1713-1721.
22. Pignon J.P., Tribodet H., Scagliotti G.V., Douillard J.Y., Shepherd F.A., Stephens R.J., Dunant A., Torri V., Rosell R., Seymour L., Spiro S.G., Rolland E., Fossati R., Aubert D., Ding K., Waller D., Le Chevalier T. Lung adjuvant cisplatin evaluation: a pooled analysis by LACE Collaborative Group. J Clin Oncol 2008, 26:3552-3559.